Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
Japan · Delayed Price · Currency is JPY 307.00
+3.00 (0.99%)
Aug 7, 2025, 3:30 PM JST
Exscientia Revenue
In the fiscal year ending March 31, 2012, Wakamoto Pharmaceutical had annual revenue of 9.43B JPY, down -2.45%. Wakamoto Pharmaceutical had revenue of 2.25B in the quarter ending March 31, 2012, a decrease of -10.25%.
Revenue
9.43B
Revenue Growth
-2.45%
P/S Ratio
1.12
Revenue / Employee
23.40M
Employees
403
Market Cap
10.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2012 | 9.43B | -237.00M | -2.45% |
| Mar 31, 2011 | 9.67B | -107.71M | -1.10% |
| Mar 31, 2010 | 9.78B | -303.57M | -3.01% |
| Mar 31, 2009 | 10.08B | -88.89M | -0.87% |
| Mar 31, 2008 | 10.17B | -158.76M | -1.54% |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,924.68B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |